These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 36603162

  • 1. A new series of hydrazones as small-molecule aldose reductase inhibitors.
    Altıntop MD, Demir Y, Türkeş C, Öztürk RB, Cantürk Z, Beydemir Ş, Özdemir A.
    Arch Pharm (Weinheim); 2023 Apr; 356(4):e2200570. PubMed ID: 36603162
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and characterization of novel acyl hydrazones derived from vanillin as potential aldose reductase inhibitors.
    Demir Y, Tokalı FS, Kalay E, Türkeş C, Tokalı P, Aslan ON, Şendil K, Beydemir Ş.
    Mol Divers; 2023 Aug; 27(4):1713-1733. PubMed ID: 36103032
    [Abstract] [Full Text] [Related]

  • 3. Biological effects of bis-hydrazone compounds bearing isovanillin moiety on the aldose reductase.
    Yapar G, Esra Duran H, Lolak N, Akocak S, Türkeş C, Durgun M, Işık M, Beydemir Ş.
    Bioorg Chem; 2021 Dec; 117():105473. PubMed ID: 34768205
    [Abstract] [Full Text] [Related]

  • 4. Design, synthesis, in vitro and in silico investigation of aldose reductase inhibitory effects of new thiazole-based compounds.
    Sever B, Altıntop MD, Demir Y, Akalın Çiftçi G, Beydemir Ş, Özdemir A.
    Bioorg Chem; 2020 Sep; 102():104110. PubMed ID: 32739480
    [Abstract] [Full Text] [Related]

  • 5. Identification of a new class of potent aldose reductase inhibitors: Design, microwave-assisted synthesis, in vitro and in silico evaluation of 2-pyrazolines.
    Sever B, Altıntop MD, Demir Y, Yılmaz N, Akalın Çiftçi G, Beydemir Ş, Özdemir A.
    Chem Biol Interact; 2021 Aug 25; 345():109576. PubMed ID: 34252406
    [Abstract] [Full Text] [Related]

  • 6. Novel acetic acid derivatives containing quinazolin-4(3H)-one ring: Synthesis, in vitro, and in silico evaluation of potent aldose reductase inhibitors.
    Tokalı FS, Demir Y, Türkeş C, Dinçer B, Beydemir Ş.
    Drug Dev Res; 2023 Apr 25; 84(2):275-295. PubMed ID: 36598092
    [Abstract] [Full Text] [Related]

  • 7. In vitro studies of potent aldose reductase inhibitors: Synthesis, characterization, biological evaluation and docking analysis of rhodanine-3-hippuric acid derivatives.
    Celestina SK, Sundaram K, Ravi S.
    Bioorg Chem; 2020 Apr 25; 97():103640. PubMed ID: 32086051
    [Abstract] [Full Text] [Related]

  • 8. Determination of the inhibition profiles of pyrazolyl-thiazole derivatives against aldose reductase and α-glycosidase and molecular docking studies.
    Demir Y, Taslimi P, Koçyiğit ÜM, Akkuş M, Özaslan MS, Duran HE, Budak Y, Tüzün B, Gürdere MB, Ceylan M, Taysi S, Gülçin İ, Beydemir Ş.
    Arch Pharm (Weinheim); 2020 Dec 25; 353(12):e2000118. PubMed ID: 32761859
    [Abstract] [Full Text] [Related]

  • 9. Screening inhibitory effects of selected flavonoids on human recombinant aldose reductase enzyme: in vitro and in silico study.
    Comakli V, Adem S, Oztekin A, Demirdag R.
    Arch Physiol Biochem; 2022 Oct 25; 128(5):1368-1374. PubMed ID: 32463711
    [Abstract] [Full Text] [Related]

  • 10. N-substituted phthalazine sulfonamide derivatives as non-classical aldose reductase inhibitors.
    Türkeş C, Arslan M, Demir Y, Çoçaj L, Nixha AR, Beydemir Ş.
    J Mol Recognit; 2022 Dec 25; 35(12):e2991. PubMed ID: 36073557
    [Abstract] [Full Text] [Related]

  • 11. Synthesis and aldose reductase inhibition effects of celecoxib derivatives containing pyrazole linked-sulfonamide moiety.
    Bayrak C.
    Bioorg Chem; 2022 Nov 25; 128():106086. PubMed ID: 35973306
    [Abstract] [Full Text] [Related]

  • 12. Hydrazide-hydrazones as Small Molecule Tropomyosin Receptor Kina se A (TRKA) Inhibitors: Synthesis, Anticancer Activities, In silico ADME and Molecular Docking Studies.
    Alam MS, Lee DU.
    Med Chem; 2022 Nov 25; 19(1):47-63. PubMed ID: 35490310
    [Abstract] [Full Text] [Related]

  • 13. Novel synthesis of nitro-quinoxalinone derivatives as aldose reductase inhibitors.
    Hussain S, Parveen S, Qin X, Hao X, Zhang S, Chen X, Zhu C, Ma B.
    Bioorg Med Chem Lett; 2014 May 01; 24(9):2086-9. PubMed ID: 24726808
    [Abstract] [Full Text] [Related]

  • 14. Coumarin-thiazole and -oxadiazole derivatives: Synthesis, bioactivity and docking studies for aldose/aldehyde reductase inhibitors.
    Ibrar A, Tehseen Y, Khan I, Hameed A, Saeed A, Furtmann N, Bajorath J, Iqbal J.
    Bioorg Chem; 2016 Oct 01; 68():177-86. PubMed ID: 27544072
    [Abstract] [Full Text] [Related]

  • 15. Synthesis and biological evaluation of new epalrestat analogues as aldose reductase inhibitors (ARIs).
    Reddy TN, Ravinder M, Bagul P, Ravikanti K, Bagul C, Nanubolu JB, Srinivas K, Banerjee SK, Rao VJ.
    Eur J Med Chem; 2014 Jan 01; 71():53-66. PubMed ID: 24275248
    [Abstract] [Full Text] [Related]

  • 16. Synthesis and activity of a new series of (Z)-3-phenyl-2-benzoylpropenoic acid derivatives as aldose reductase inhibitors.
    Wang SJ, Yan JF, Hao D, Niu XW, Cheng MS.
    Molecules; 2007 Apr 30; 12(4):885-95. PubMed ID: 17851441
    [Abstract] [Full Text] [Related]

  • 17. (4-Oxo-2-thioxothiazolidin-3-yl)acetic acids as potent and selective aldose reductase inhibitors.
    Kucerova-Chlupacova M, Halakova D, Majekova M, Treml J, Stefek M, Soltesova Prnova M.
    Chem Biol Interact; 2020 Dec 01; 332():109286. PubMed ID: 33038328
    [Abstract] [Full Text] [Related]

  • 18. Synthesis and structure-activity relationship studies of quinoxaline derivatives as aldose reductase inhibitors.
    Wu B, Yang Y, Qin X, Zhang S, Jing C, Zhu C, Ma B.
    ChemMedChem; 2013 Dec 01; 8(12):1913-7. PubMed ID: 24115741
    [Abstract] [Full Text] [Related]

  • 19. Design and synthesis of novel quinazolin-4(1H)-one derivatives as potent and selective inhibitors targeting AKR1B1.
    Han Z, Li J, Xu Z, Su Y, Wang Y, Zhuo L, Du J, Zhu C, Hao X.
    Arch Pharm (Weinheim); 2023 Apr 01; 356(4):e2200577. PubMed ID: 36707406
    [Abstract] [Full Text] [Related]

  • 20. Development of coumarin-thiosemicarbazone hybrids as aldose reductase inhibitors: Biological assays, molecular docking, simulation studies and ADME evaluation.
    Imran A, Tariq Shehzad M, Al Adhami T, Miraz Rahman K, Hussain D, Alharthy RD, Shafiq Z, Iqbal J.
    Bioorg Chem; 2021 Oct 01; 115():105164. PubMed ID: 34314916
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.